Yariv Houvras
CIK: 0002154870
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
XLO
Xilio Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
About Houvras Yariv
Houvras Yariv (SEC CIK 0002154870) files insider reports with the SEC as CHIEF MEDICAL OFFICER of Xilio Therapeutics, Inc. (XLO).
Signal8 holds 2 ownership filings by Houvras Yariv (1 Form 3, 1 Form 4), filed on Oct 2, 2026. Those filings report 1 transaction, the latest on Oct 1, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Houvras Yariv's filings is in WALTHAM, MA.
Recent filings by Houvras Yariv
- Oct 1, 2026: Grant or award of XLO derivative securities (Form 4, code A).
Other insiders filing for Xilio Therapeutics, Inc. (XLO)
- Bello Akintunde Olatokumbo, Director
- Shannon James Samuel, Director
- Curran Daniel J., Director
- Xu Yuan, Director
- ROSS ROBERT W., Director
- Bonstein Sara, Director